Emeren Group Stock Price, News & Analysis (NYSE:SOL)

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Emeren Group in the last year. There are currently 1 hold rating, 2 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" SOL shares.
View SOL analyst ratings or view top-rated stocks.

4 Wall Street analysts have issued 12-month price targets for Emeren Group's stock. Their SOL share price targets range from $3.20 to $8.00. On average, they anticipate the company's share price to reach $5.80 in the next twelve months. This suggests a possible upside of 131.5% from the stock's current price.
View analysts price targets for SOL or view top-rated stocks among Wall Street analysts.

Emeren Group's stock was trading at $4.52 at the start of the year. Since then, SOL stock has decreased by 44.6% and is now trading at $2.5050.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 26th 2024.
View our SOL earnings forecast.

Emeren Group Ltd (NYSE:SOL) released its quarterly earnings results on Tuesday, December, 7th. The semiconductor company reported $0.01 earnings per share for the quarter, missing the consensus estimate of $0.04 by $0.03. The semiconductor company earned $15.54 million during the quarter, compared to the consensus estimate of $20.22 million. Emeren Group had a trailing twelve-month return on equity of 3.19% and a net margin of 3.55%. During the same period last year, the company posted $0.05 earnings per share.

ETFs with the largest weight of Emeren Group (NYSE:SOL) stock in their portfolio include ProShares S&P Kensho Cleantech ETF (CTEX), SPDR S&P Kensho Clean Power ETF (CNRG) and Global X Solar ETF (RAYS).Invesco Solar ETF (TAN).

Shares of Emeren Group reverse split before market open on Friday, February 10th 2017. The 1-5 reverse split was announced on Monday, January 30th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, February 9th 2017. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

Emeren Group issued an update on its fourth quarter 2023 earnings guidance on Tuesday, November, 21st. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $50.00 million-$53.00 million, compared to the consensus revenue estimate of $80.48 million.

34 employees have rated Emeren Group Chief Executive Officer Xian Shou Li on Glassdoor.com. Xian Shou Li has an approval rating of 28% among the company's employees. This puts Xian Shou Li in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Emeren Group investors own include Co-Diagnostics (CODX), Inovio Pharmaceuticals (INO), Nokia Oyj (NOK), FuelCell Energy (FCEL), Advanced Micro Devices (AMD), SunPower (SPWR), VBI Vaccines (VBIV), First Solar (FSLR), Onconova Therapeutics (ONTX) and OPKO Health (OPK).

Emeren Group's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Invesco Ltd. (4.20%), Legal & General Group Plc (2.15%), Monaco Asset Management SAM (0.92%), GSA Capital Partners LLP (0.89%), Raymond James Financial Services Advisors Inc. (0.19%) and Quadrature Capital Ltd (0.10%).
View institutional ownership trends.

Shares of SOL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.